Alan P. Kumar, Ph.D.
Affiliations: | 2003 | University of North Texas, Denton, TX, United States |
Area:
Molecular BiologyGoogle:
"Alan Kumar"Parents
Sign in to add mentorGerard A. O'Donovan | grad student | 2003 | University of North Texas | |
(Structure-function studies on aspartate transcarbamoylase and regulation of pyrimidine biosynthesis by a positive activator protein, PyrR in Pseudomonas putida.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Manickasamy MK, Jayaprakash S, Girisa S, et al. (2024) Delineating the role of nuclear receptors in colorectal cancer, a focused review. Discover. Oncology. 15: 41 |
Gupta N, Mohan CD, Shanmugam MK, et al. (2023) CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/CXCR4 signaling axis in preclinical breast cancer model. Environmental Research. 232: 116335 |
Ang HL, Mohan CD, Shanmugam MK, et al. (2023) Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Medicinal Research Reviews |
Tuli HS, Rath P, Chauhan A, et al. (2022) Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends. Biomolecules. 13 |
Jayaprakash S, Hegde M, Girisa S, et al. (2022) Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer. International Journal of Molecular Sciences. 23 |
Jung YY, Mohan CD, Eng H, et al. (2022) 2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells. Biomolecules. 12 |
Paskeh MDA, Entezari M, Mirzaei S, et al. (2022) Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology. 15: 83 |
Jung YY, Chinnathambi A, Alahmadi TA, et al. (2022) Fangchinoline targets epithelial-mesenchymal transition process by modulating activation of multiple cell-signaling pathways. Journal of Cellular Biochemistry |
Paskeh MDA, Saebfar H, Mahabady MK, et al. (2022) Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sciences. 120463 |
Yang MH, Jung SH, Um JY, et al. (2022) Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells. Life Sciences. 120395 |